Skip to content

Analgesia

Analgesia

We have been committed to furthering the understanding and treatment of pain for over 35 years, using our expertise in prolonged release technology to reduce the dosing frequency for patients, with the aim of ensuring continuous pain relief around the clock. Since we launched our first product in this field, we have expanded our portfolio, with the aim of providing health professionals with a broad range from which to select the most appropriate treatment for their patients.

© 2025 NAPP PHARMACEUTICALS LIMITED. DOP: July 2024 UK-CORP-2200003 v10.0

Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”

Napp
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.